Special techniques for imaging blood flow to tumors

Cancer Journal

Volumn 8, Issue 2, 2002, Pages 109-118

  Choyke, Peter L ^a,b   Knopp, Michael V ^a   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer; Flow; Imaging; MRI; PET; Ultrasound

Indexed keywords

CHOLINE; CONTRAST MEDIUM; DOPAMINE; FLUORODEOXYGLUCOSE; GADOLINIUM CHELATE; INTEGRIN; IODINATED CONTRAST MEDIUM; PROGESTERONE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT;

BLOOD RHEOLOGY; BREAST CANCER; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG HYPERSENSITIVITY; HUMAN; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TUMOR; TUMOR VASCULARIZATION; ULTRASOUND; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0036519221     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200203000-00005     Document Type: Review

References (56)

1. Jain RK. Understanding barriers to drug delivery: high resolution in vivo imaging is key [editorial; comment]. Clin Cancer Res 1999;5:1605-1606.
2. Folkman J. Tumor angiogenesis: role in regulation of tumor growth. Symp Soc Dev Biol 1974;30:43-52.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
4. Padhani AR, Husband JE.Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001;56:607-620.
5. Weber WA, Haubner R, Vabuliene E et al. Tumor angiogenesis targeting using imaging agents. Q J Nucl Med 2001;45:179-182.
6. Jain RK. The Eugene M. Landis Award Lecture 1996: delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997;4:1-23.
7. Jain RK. Delivery of molecular and cellular medicine to solid tumors. J Controlled Release 1998;53:49-67.
8. Hashizume H, Baluk P, Morikawa S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-1380.
9. Brasch RC, Li KC, Husband JE et al. In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 2000;7:812-823.
10. Padhani AR, Husband JE. Commentary. Are current tumour response criteria relevant for the 21st century? Br J Radiol 2000;73:1031-1033.
11. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90.
12. Knopp MV, Weiss E, Sinn HP et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-266.
13. Taylor JS, Tofts PS, Port R et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999;10:903-907.
14. Brix G, Semmler W, Port R et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
15. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568.
16. Brasch R, Pham C, Shames D et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
17. Knopp MV, von Tengg-Kobligk H, Floemer F et al. Contrast agents for MRA: future directions. J Magn Reson Imaging 1999;10:314-316.
18. Knopp MV, Brix G, Junkermann HJ et al. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 1994;2:633-658.
19. Hoffmann U, Brix G, Knopp MV et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
20. Hawighorst H, Knopp MV, Debus J et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 1998;8:783-788.
21. Hawighorst H, Knapstein PG, Weikel W et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57:4777-4786.
22. Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001;3:22-27.
23. Buadu LD, Murakami J, Murayama S et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-649.
24. Reddick WE, Taylor JS, Fletcher BD. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma. J Magn Reson Imaging 1999;10:277-285.
25. Turetschek K, Roberts TP, Floyd E et al. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 2001;13:882-888.
26. Price P. PET as a potential tool for imaging molecular mechanisms of oncology in man. Trends Mol Med 2001;7:442-446.
27. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001;39:883-917.
28. Salminen E, MacManus M. Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer. Ann Med 2001;33:404-409.
29. Gungor T, Engel-Bicik I, Eich G et al. Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 2001;85:341-345.
30. Tochon-Danguy HJ, Sachinidis JI, Egan GF et al. Positron emission tomography: radioisotope and radiopharmaceutical production. Australas Phys Eng Sci Med 1999;22:136-144.
31. Iida H, Yokoyama I, Agostini D et al. Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan. Eur J Nucl Med 2000;27:192-201.
32. Ziegler SI, Haberkorn U, Byrne H et al. Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 1996;23:169-177.
33. Haubner R, Wester HJ, Weber WA et al. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001;61:1781-1785.
34. Aronen HJ, Pardo FS, Kennedy DN et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189-2200.
35. Libutti SK, Choyke P, Carrasquillo JA et al. Monitoring responses to antiangiogenic agents using noninvasive imaging tests. Cancer J Sci Am 1999;5:252-256.
36. Miles KA, Charnsangavej C, Lee FT et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7:840-850.
37. Miles KA, Kelley BB. CT measurements of capillary permeability within nodalmasses: a potential technique for assessing the activity of lymphoma. Br J Radiol 1997;70:74-79.
38. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol 1999;30:198-205.
39. Platt JF, Francis IR, Ellis JH et al. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology 1997;205:49-53.
40. Leggett DA, Kelley BB, Bunce IHet al. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997;205:716-720.
41. Swensen SJ, Brown LR, Colby TV et al. Lung nodule enhancement at CT: prospective findings. Radiology 1996;201:447-455.
42. Swensen SJ, Viggiano RW, Midthun DE et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80.
43. Tateishi U, Nishihara H, Watanabe S et al. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr 2001;25:23-27.
44. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997;205:471-478.
45. Wan SY, Kiraly AP, Ritman EL et al. Extraction of the hepatic vasculature in rats using 3-D micro-CT images. IEEE Trans Med Imaging 2000;19:964-971.
46. Skyba DM, Price RJ, Linka AZ et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998;98:290-293.
47. Young SR, Dyson M. The effect of therapeutic ultrasound on angiogenesis. Ultrasound Med Biol 1990;16:261-269.
48. Lassau N, Koscielny S, Opolon P et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol 2001;36:50-55.
49. Delorme S, Huber S. Doppler sonography of breast tumours. Anticancer Res 1998;18:2155-2158.
50. Mehta TS, Raza S, Baum JK. Use of Doppler ultrasound in the evaluation of breast carcinoma. Semin Ultrasound CT MR 2000;21:297-307.
51. Lee CN, Cheng WF, Chen CA et al. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol 2000;96:615-621.
52. Cheng WF, Wei LH, Su YN et al. The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix. Br J Obstet Gynaecol 1999;106:1137-1142.
53. Cheng WF, Lee CN, Chu JS et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999;85:651-657.
54. Peters-Engl C, Medl M, Mirau M et al. Color-coded and spectral Doppler flow in breast carcinomas: relationship with the tumor microvasculature. Breast Cancer Res Treat 1998;47:83-89.
55. Suren A, Osmers R, Kuhn W. 3D Color Power Angio imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 1998;11:133-137.
56. Lassau N, Paturel-Asselin C, Guinebretiere JMet al. New hemodynamic approach to angiogenesis: color and pulsed Doppler ultrasonography. Invest Radiol 1999;34:194-198.